tradingkey.logo

Biomerica Inc

BMRA
View Detailed Chart
2.650USD
+0.030+1.15%
Close 12/24, 13:00ETQuotes delayed by 15 min
7.46MMarket Cap
LossP/E TTM

Biomerica Inc

2.650
+0.030+1.15%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.15%

5 Days

+10.88%

1 Month

+15.72%

6 Months

-16.14%

Year to Date

+10.38%

1 Year

+19.15%

View Detailed Chart

TradingKey Stock Score of Biomerica Inc

Currency: USD Updated: 2025-12-24

Key Insights

Biomerica Inc's fundamentals are relatively very healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 150/206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.In the medium term, the stock price is expected to remain stable.Despite a good stock market performance over the past month, the company shows weak fundamentals and technicals, which don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Biomerica Inc's Score

Industry at a Glance

Industry Ranking
150 / 206
Overall Ranking
445 / 4562
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Biomerica Inc Highlights

StrengthsRisks
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.
Growing
The company is in a growing phase, with the latest annual income totaling USD 5.31M.
Fairly Valued
The company’s latest PE is -1.72, at a medium 3-year percentile range.
Held by The Vanguard
Star Investor The Vanguard holds 21.13K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.18.

Biomerica Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Biomerica Inc Info

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.
Ticker SymbolBMRA
CompanyBiomerica Inc
CEOIrani (Zackary S)
Websitehttps://biomerica.com/

FAQs

What is the current price of Biomerica Inc (BMRA)?

The current price of Biomerica Inc (BMRA) is 2.650.

What is the symbol of Biomerica Inc?

The ticker symbol of Biomerica Inc is BMRA.

What is the 52-week high of Biomerica Inc?

The 52-week high of Biomerica Inc is 10.160.

What is the 52-week low of Biomerica Inc?

The 52-week low of Biomerica Inc is 2.110.

What is the market capitalization of Biomerica Inc?

The market capitalization of Biomerica Inc is 7.46M.

What is the net income of Biomerica Inc?

The net income of Biomerica Inc is -4.97M.

Is Biomerica Inc (BMRA) currently rated as Buy, Hold, or Sell?

According to analysts, Biomerica Inc (BMRA) has an overall rating of --, with a price target of --.

What is the Earnings Per Share (EPS TTM) of Biomerica Inc (BMRA)?

The Earnings Per Share (EPS TTM) of Biomerica Inc (BMRA) is -1.538.
KeyAI